ArticleCancers2022

Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry.

Jorge Labrador et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.